Q: Interesting that Well Health has shot up 8% this morning. Was there any news? Could there be a potential short squeeze occurring?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Do you see BYD as fully valued or would KXS have more room to grow?
Thank you. Excellent site!
Thank you. Excellent site!
Q: Great article on Csu and its founder Leonard by Andrew Willis, Apr26 Globe and Mail Report on Business
Q: Hello,
Interested in your answer earlier this morning that you believe WELL at $5.75 is attractive and what you based that value on? This concerning to me as many questions have been asked of your team top picks as to where to deploy new money over the past months and WELL was more often than not included in the answer. At these points WELL was trading between $7-$9 range. So fundamentally, what has changed?
Interested in your answer earlier this morning that you believe WELL at $5.75 is attractive and what you based that value on? This concerning to me as many questions have been asked of your team top picks as to where to deploy new money over the past months and WELL was more often than not included in the answer. At these points WELL was trading between $7-$9 range. So fundamentally, what has changed?
Q: Do you believe Magna is a buy at today's price?
Q: Thanks for your great services. Earlier during Covid, I put in an order for well at $4.20, but only 10% of the order was filled. I've watched my tiny position do well over the last 6 months - wishing I had a larger position, LOL. I guess it's anyone's guess how low the stock could go - perhaps you can comment on that. Can you recommend an entry price for a bargain hunter?
Q: Gentlemen, is REAL a value play or value trap?
My understanding is that the pandemic reduced the requirement for in person real estate appraisals, hurting REAL despite the uptick in real estate activity. Going forward I can see things reverting back to normal for appraisals. Any interest rate increases will certainly hurt mortgage renewals. Analysts however seem to think the growth story is largely intact.
Thanks for everything you do.
My understanding is that the pandemic reduced the requirement for in person real estate appraisals, hurting REAL despite the uptick in real estate activity. Going forward I can see things reverting back to normal for appraisals. Any interest rate increases will certainly hurt mortgage renewals. Analysts however seem to think the growth story is largely intact.
Thanks for everything you do.
Q: Hello,
In a follow up to my prior question. Can you please give your specific take with respect to the specific issues outlined in the short report. I am aware that it may require some research so please feel free to take your time in response to this question.
- divesture of Silicon Valley buyer
- data breaches
- CRH key customer renewal not looking good
- the outbidding of itself for key assets like source 44
- circle’s shareholders cashing out.
In a follow up to my prior question. Can you please give your specific take with respect to the specific issues outlined in the short report. I am aware that it may require some research so please feel free to take your time in response to this question.
- divesture of Silicon Valley buyer
- data breaches
- CRH key customer renewal not looking good
- the outbidding of itself for key assets like source 44
- circle’s shareholders cashing out.
Q: Is it too late to start a position in these 2 stocks? Txs for u usual great services & views
Q: a lot of discussions today on why WELL is so bad, yet today TD upgraded stock price from $10 to $10.50 ... is this simply showing symbolic support based on their DD, or am I reading to much into this upgrade
Q: WELL is sinking like a rock based on this short report. Grizzlyreports.com/we-believe-well-health-technologies-is-a-toxic-roll-up
What are you thoughts on the issues:
- divesture of Silicon Valley buyer
- data breaches
- CRH key customer renewal not looking good
- the outbidding of itself for key assets like source 44
- circle’s shareholders cashing out.
- etc
What are you thoughts on the issues:
- divesture of Silicon Valley buyer
- data breaches
- CRH key customer renewal not looking good
- the outbidding of itself for key assets like source 44
- circle’s shareholders cashing out.
- etc
Q: Breaking News on BNN a few mins ago that there was a Short seller on Well .Please comment. Current price $6.70 -0.30 on1.6m shares exceeding 943k(3 mos average)
Q: Hello 5i,
What is your take on the Knight Theraputics deal and thoughts on the stock in general? Is it a buy here?
What is your take on the Knight Theraputics deal and thoughts on the stock in general? Is it a buy here?
Q: There is currently a lot of selling pressure with this stock. Is there a way to tell it could be a short attack and do you think it is.
Q: Hi, Do u think Sylogist can keep moving upwards with the recent momentum after not doing a whole lot for several years, thanks?
Q: Since its last financing @ $9.80(all paid by billionarie Mr K.S.Li & his rich friends),CRH has declined to current $7(near its other $6.75 financing partially funded by Mr Li) Have a 3.5% position,p/p $8.37.Add or hold.Please comment.Txs for u usual great views & services
Q: hi guys i was wondering if you could explain in layman terms what is the reason for recent volatility .I realize they are selling debt but how does that facilitate shorting the stock
Q: Hi,
What happened in 2019 that caused EGLX to drop so dramatically? Has that reason now been addressed in your mind?
Thanks
Robert
What happened in 2019 that caused EGLX to drop so dramatically? Has that reason now been addressed in your mind?
Thanks
Robert
Q: Hi 5i,
Would you give me your thoughts on ATA for a 5 year hold.
Thanks,
Earl
Would you give me your thoughts on ATA for a 5 year hold.
Thanks,
Earl
Q: Supply chains seems to be a growing area of business focus. Managing them well may become even more important in the future given circumstances with the pandemic. Would you be able to provide some insight into Kinaxis' main competitors and where it stands in the field? How would you rank it? (Take multiple credits.)